Christer Halldin Selected Research

G-Protein-Coupled Receptors (Receptors, G Protein Coupled)

1/2022	Synthesis and Preclinical Evaluation of [11C]AZ11895530 for PET Imaging of the Serotonin 1A Receptor.
11/2017	[11C]AZ10419096 - a full antagonist PET radioligand for imaging brain 5-HT1B receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christer Halldin Research Topics

Disease

30	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2009
22	Schizophrenia (Dementia Praecox) 01/2024 - 01/2002
21	Parkinson Disease (Parkinson's Disease) 10/2023 - 10/2004
16	Mental Disorders (Mental Disorder) 01/2023 - 03/2002
13	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2023 - 04/2008
13	Neuroinflammatory Diseases 01/2021 - 01/2009
10	Huntington Disease (Huntington's Disease) 12/2023 - 10/2011
9	Major Depressive Disorder (Major Depressive Disorders) 10/2021 - 11/2011
4	Cognitive Dysfunction 01/2024 - 01/2016
4	Gliosis 01/2023 - 01/2011
4	Breast Neoplasms (Breast Cancer) 12/2022 - 06/2010
4	Stroke (Strokes) 04/2016 - 11/2002
4	Amyloid Plaque 09/2015 - 08/2010
3	Neoplasms (Cancer) 12/2023 - 12/2021
3	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2019
3	Disease Progression 01/2020 - 01/2012
3	Infarction (Infarctions) 04/2016 - 01/2012
2	Brain Neoplasms (Brain Tumor) 11/2023 - 01/2020
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 01/2008
2	Dyskinesias (Dyskinesia) 01/2019 - 10/2018
2	Hypersensitivity (Allergy) 01/2018 - 02/2011
2	Ischemic Stroke 04/2016 - 09/2012
2	Obesity 02/2016 - 03/2014
2	Mood Disorders (Mood Disorder) 02/2015 - 10/2013
2	Anxiety Disorders (Anxiety Disorder) 02/2014 - 11/2013
2	Nervous System Diseases (Neurological Disorders) 06/2013 - 01/2010
2	Multiple Sclerosis 04/2013 - 01/2008
2	Juvenile Myoclonic Epilepsy 02/2012 - 06/2005
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2006 - 02/2005
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2002 - 08/2002
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2023
1	Glioma (Gliomas) 11/2023
1	Multiple System Atrophy 10/2023

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2009
15	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 05/2002
15	Serotonin (5 Hydroxytryptamine)IBA 01/2023 - 03/2002
14	Biomarkers (Surrogate Marker)IBA 08/2020 - 04/2008
12	Amyloid (Amyloid Fibrils)IBA 01/2024 - 11/2009
10	LigandsIBA 10/2023 - 01/2009
10	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 04/2023 - 09/2000
8	EnzymesIBA 01/2023 - 01/2011
7	Dopamine Receptors (Dopamine Receptor)IBA 01/2020 - 05/2002
6	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2020 - 06/2016
6	vinpocetineIBA 09/2012 - 08/2002
5	Monoamine Oxidase (MAO)IBA 01/2023 - 01/2011
5	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 05/2002
5	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 10/2021 - 01/2003
5	5-HT1B Serotonin ReceptorIBA 01/2019 - 07/2008
5	RacloprideIBA 05/2012 - 02/2005
4	2- (6- (methylamino)pyridin- 3- yl)- 1,3- benzothiazol- 6- olIBA 01/2024 - 11/2009
4	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2019 - 09/2006
4	Amyloid beta-PeptidesIBA 01/2018 - 10/2010
3	5-HT1A Serotonin ReceptorIBA 01/2022 - 06/2005
3	GABA-A Receptors (GABA(A) Receptor)IBA 01/2021 - 01/2009
3	Neurotransmitter Agents (Neurotransmitter)IBA 03/2017 - 12/2014
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 03/2014 - 02/2012
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 06/2013 - 06/2010
3	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 04/2013 - 01/2008
3	Peptides (Polypeptides)IBA 04/2012 - 01/2012
3	FLB 457IBA 12/2006 - 01/2002
3	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 12/2006 - 01/2002
2	pyrimidineIBA 12/2023 - 01/2021
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 11/2017
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021 - 10/2016
2	polyglutamineIBA 01/2021 - 01/2020
2	Metabotropic Glutamate 5 ReceptorIBA 01/2020 - 01/2018
2	Ketamine FDA LinkGeneric 01/2020 - 03/2015
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2020 - 07/2019
2	Levodopa (L Dopa)FDA LinkGeneric 01/2019 - 10/2018
2	SCH 23390IBA 01/2019 - 05/2002
2	metabotropic glutamate receptor 4IBA 01/2019 - 10/2018
2	Antidepressive Agents (Antidepressants)IBA 01/2019 - 08/2008
2	VortioxetineIBA 01/2019 - 10/2013
2	Insulin (Novolin)FDA Link 12/2018 - 03/2015
2	Glutamic Acid (Glutamate)FDA Link 01/2018 - 02/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2017 - 09/2015
2	Peroxidase (Myeloperoxidase)IBA 09/2015 - 06/2015
2	AZD3241IBA 09/2015 - 06/2015
2	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 03/2015 - 09/2006
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2015 - 12/2014
2	Quetiapine Fumarate (Seroquel)FDA Link 11/2013 - 11/2011
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 08/2013 - 09/2012
2	N- (5- fluoro- 2- phenoxyphenyl)- N- (2- fluoroethyl- 5- methoxybenzyl)acetamideIBA 06/2013 - 04/2013
2	4- cyano- 1- (2- iodophenyl)- 5- (4- methoxyphenyl)- N- (piperidin- 1- yl)- 1H- pyrazole- 3- carboxamideIBA 04/2012 - 02/2012
2	N- (3- iodoprop- 2- enyl)- 2- beta- carbomethoxy- 3- (4- methylphenyl)nortropaneIBA 02/2012 - 02/2005
2	Clozapine (Clozaril)FDA LinkGeneric 11/2011 - 03/2003
2	multidrug resistance-associated protein 1IBA 02/2011 - 06/2010
1	AMPA Receptors (AMPA Receptor)IBA 01/2024
1	FAPI-46IBA 12/2023
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 12/2023
1	Huntingtin ProteinIBA 12/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2023
1	DNA (Deoxyribonucleic Acid)IBA 11/2023
1	MethyltransferasesIBA 11/2023
1	SynucleinsIBA 10/2023
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 06/2023
1	Nerve Growth Factors (Neurotrophins)IBA 01/2023

Therapy/Procedure

4	Therapeutics 01/2017 - 01/2012
2	Aftercare (After-Treatment) 10/2021 - 09/2015
2	Oral Administration 03/2017 - 08/2002